Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Batlle

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Neurologia|September 5, 2022
Gadolinium-enhanced brain lesions in multiple sclerosis relapseL Martín-Aguilar, S Presas-Rodriguez, À Rovira, et al.
Revista De Neurologia|May 18, 2010
[Multiple sclerosis epidemiological situation update: pertinence and set-up of a population based registry of new cases in Catalonia]S Otero, J Batlle, I Bonaventura, et al.
Journal of Thrombosis and Haemostasis : JTH|April 6, 2007
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)A Tosetto, F Rodeghiero, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWDJ Eikenboom, V Van Marion, H Putter, et al.
Journal of Thrombosis and Haemostasis : JTH|March 5, 2008
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)U Budde, R Schneppenheim, J Eikenboom, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2009
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD studyJ Eikenboom, L Hilbert, A S Ribba, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Neurologia|September 5, 2022
Gadolinium-enhanced brain lesions in multiple sclerosis relapseL Martín-Aguilar, S Presas-Rodriguez, À Rovira, et al.
Revista De Neurologia|May 18, 2010
[Multiple sclerosis epidemiological situation update: pertinence and set-up of a population based registry of new cases in Catalonia]S Otero, J Batlle, I Bonaventura, et al.
Journal of Thrombosis and Haemostasis : JTH|April 6, 2007
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)A Tosetto, F Rodeghiero, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWDJ Eikenboom, V Van Marion, H Putter, et al.
Journal of Thrombosis and Haemostasis : JTH|March 5, 2008
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)U Budde, R Schneppenheim, J Eikenboom, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2009
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD studyJ Eikenboom, L Hilbert, A S Ribba, et al.
Pageof 11